Estrogenic compounds have divergent effects on human endothelial progenitor cell migration according to sex of the donor

Journal of Vascular Research

Volumn 52, Issue 4, 2015, Pages 273-278

  Campesi, Ilaria ^a,b   Capobianco, Giampiero ^a   Dessole, Salvatore ^a   Occhioni, Stefano ^a,b   Montella, Andrea ^a   Franconi, Flavia ^a,c  

^a UNIVERSITY OF SASSARI   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c Assessorato alle Politiche per la Persona of Basilicata Region   (Italy)

Author keywords

(R,R) 5,11 diethyl 5,6,11,12 tetrahydro 2,8 chrysenediol; 17 Estradiol; Bisphenol A; Endothelial progenitor cells; Migration; Sex

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; 5,11 DIETHYL 5,6,11,12 TETRAHYDRO 2,8 CHRYSENEDIOL; CHRYSENE DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ESR2 PROTEIN, HUMAN; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN;

ADULT; ARTICLE; CELL MIGRATION; CHEMOTAXIS ASSAY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MIGRATION INHIBITION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; WESTERN BLOTTING; ADOLESCENT; AGONISTS; CELL CULTURE; CHEMOTAXIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; CELLS, CULTURED; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL PROGENITOR CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; MALE; SEX FACTORS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84957922765     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000443403     Document Type: Article

References (33)

1. van Craenenbroeck EM, Conraads VM. Endothelial progenitor cells in vascular health: focus on lifestyle. Microvasc Res 2010; 79: 184-192
2. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600
3. Lee PS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells 2014; 6: 355-366
4. Hoetzer GL, MacEneaney OJ, Irmiger HM, Keith R, van Guilder GP, Stauffer BL, DeSouza CA. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007; 99: 46-48
5. Bulut D, Albrecht N, Imohl M, Gunesdogan B, Bulut-Streich N, Borgel J, Hanefeld C, Krieg M, Mugge A: Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 2007; 96: 258-263
6. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, Cignarella A, Bolego C, Plebani M, Nardelli GB, Sartore S, Agostini C, Avogaro A: Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008; 28: 997-1004
7. Cignarella A, Fadini GP. Enhancing endothelial progenitor cell function through selective estrogen receptor modulation: A potential approach to cardiovascular risk reduction. Cardiovasc Hematol Agents Med Chem 2010; 8: 147-155
8. Imanishi T, Tsujioka H, Akasaka T: Endothelial progenitor cell senescence - is there a role for estrogen?. Ther Adv Cardiovasc Dis 2010; 4: 55-69
9. Rubin BS. Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011; 127: 27-34
10. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863-870
11. Routledge EJ, White R, Parker MG, Sumpter JP. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ. J Biol Chem 2000; 275: 35986-35993
12. Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T, Osuga Y, Fujiwara T, Inoue S, Muramatsu M, Momoeda M, Taketani Y: The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endocr J 2002; 49: 465-471
13. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24: 139-177
14. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, Heindel JJ, Trasande L: Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015; 100: 1278-1288
15. Chevalier N, Fenichel P: Endocrine disruptors: new players in the pathophysiology of type 2 diabetes?. Diabetes Metab 2015; 41: 107-115
16. Kirkley AG, Sargis RM. Environmental endocrine disruption of energy metabolism and cardiovascular risk. Curr Diab Rep 2014; 14: 494
17. Shankar A, Teppala S, Sabanayagam C: Bisphenol A and peripheral arterial disease: results from the NHANES. Environ Health Perspect 2012; 120: 1297-1300
18. Gao X, Wang HS. Impact of bisphenol a on the cardiovascular system - epidemiological and experimental evidence and molecular mechanisms. Int J Environ Res Public Health 2014; 11: 8399-8413
19. Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, Padmanabhan V, Taylor HS, Swan SH, VandeVoort CA, Flaws JA. Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect 2014; 122: 775-786
20. Rogers JA, Metz L, Yong VW. Review: endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms. Mol Immunol 2013; 53: 421-430
21. Pellegrini M, Bulzomi P, Lecis M, Leone S, Campesi I, Franconi F, Marino M: Endocrine disruptors differently influence estrogen receptor beta and androgen receptor in male and female rat VSMC. J Cell Physiol 2014; 229: 1061-1068
22. Townsend EA, Meuchel LW, Thompson MA, Pabelick CM, Prakash YS. Estrogen increases nitric-oxide production in human bronchial epithelium. J Pharmacol Exp Ther 2011; 339: 815-824
23. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 2002; 9: 359-364
24. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- And beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003; 206: 13-22
25. Briasoulis A, Tousoulis D, Antoniades C, Papageorgiou N, Stefanadis C: The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc Ther 2011; 29: 125-139
26. Emanueli C, Monopoli A, Kraenkel N, Meloni M, Gadau S, Campesi I, Ongini E, Madeddu P: Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice. Br J Pharmacol 2007; 150: 873-882
27. Sekiguchi H, Ii M, Losordo DW. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 2009; 219: 235-242
28. Foresta C, Zuccarello D, Biagioli A, De Toni L, Prana E, Nicoletti V, Ambrosini G, Ferlin A: Oestrogen stimulates endothelial progenitor cells via oestrogen receptor-alpha. Clin Endocrinol 2007; 67: 520-525
29. Foresta C, De Toni L, Di Mambro A, Ferlin A, Perilli L, Bertuzzi I, Galan A, Zuccarello D: Role of estrogen receptors in menstrual cyclerelated neoangiogenesis and their influence on endothelial progenitor cell physiology. Fertil Steril 2010; 93: 220-228
30. Matsubara Y, Matsubara K: Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation. Reprod Biol Endocrinol 2012; 10: 2
31. Aicher A, Zeiher AM, Dimmeler S: Mobilizing endothelial progenitor cells. Hypertension 2005; 45: 321-325
32. Patel PD, Arora RR. Endothelial dysfunction: A potential tool in gender related cardiovascular disease. Ther Adv Cardiovasc Dis 2008; 2: 89-100
33. Bacon SL, Lavoie KL, Arsenault A, Dupuis J, Pilote L, Laurin C, Gordon J, Gautrin D, Vadeboncoeur A: The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology. BMC Cardiovasc Disord 2011; 11: 50